These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38635899)

  • 21. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
    Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control.
    Stone JD; Harris DT; Soto CM; Chervin AS; Aggen DH; Roy EJ; Kranz DM
    Cancer Immunol Immunother; 2014 Nov; 63(11):1163-76. PubMed ID: 25082071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
    Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY
    Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
    Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
    Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8
    Ping Y; Shan J; Qin H; Li F; Qu J; Guo R; Han D; Jing W; Liu Y; Liu J; Liu Z; Li J; Yue D; Wang F; Wang L; Zhang B; Huang B; Zhang Y
    Immunity; 2024 Sep; 57(9):2122-2139.e9. PubMed ID: 39208806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells.
    Sullivan PM; Reed SJ; Kalia V; Sarkar S
    Front Immunol; 2021; 12():706150. PubMed ID: 34867942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, Enable.
    Fabian KP; Malamas AS; Padget MR; Solocinski K; Wolfson B; Fujii R; Abdul Sater H; Schlom J; Hodge JW
    Cancer Immunol Res; 2021 Feb; 9(2):239-252. PubMed ID: 33355290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors.
    Okoye I; Xu L; Motamedi M; Parashar P; Walker JW; Elahi S
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33310773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.
    Aoki H; Shichino S; Matsushima K; Ueha S
    Front Immunol; 2022; 13():807696. PubMed ID: 35154125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.
    Kesarwani P; Chakraborty P; Gudi R; Chatterjee S; Scurti G; Toth K; Simms P; Husain M; Armeson K; Husain S; Garrett-Mayer E; Vasu C; Nishimura MI; Mehrotra S
    Oncotarget; 2016 Oct; 7(43):69371-69383. PubMed ID: 27750220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice.
    Zhang C; Lei L; Yang X; Ma K; Zheng H; Su Y; Jiao A; Wang X; Liu H; Zou Y; Shi L; Zhou X; Sun C; Hou Y; Xiao Z; Zhang L; Zhang B
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-10 receptor signaling promotes the maintenance of a PD-1
    Hanna BS; Llaó-Cid L; Iskar M; Roessner PM; Klett LC; Wong JKL; Paul Y; Ioannou N; Öztürk S; Mack N; Kalter V; Colomer D; Campo E; Bloehdorn J; Stilgenbauer S; Dietrich S; Schmidt M; Gabriel R; Rippe K; Feuerer M; Ramsay AG; Lichter P; Zapatka M; Seiffert M
    Immunity; 2021 Dec; 54(12):2825-2841.e10. PubMed ID: 34879221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.
    Sfanos KS; Bruno TC; Meeker AK; De Marzo AM; Isaacs WB; Drake CG
    Prostate; 2009 Nov; 69(15):1694-703. PubMed ID: 19670224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity.
    Adam K; Lipatova Z; Abdul Ghafoor Raja M; Mishra AK; Mariuzza RA; Workman CJ; Vignali DAA
    J Immunol; 2024 Jul; 213(1):7-13. PubMed ID: 38775415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.
    Budhu S; Schaer DA; Li Y; Toledo-Crow R; Panageas K; Yang X; Zhong H; Houghton AN; Silverstein SC; Merghoub T; Wolchok JD
    Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
    Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
    Front Immunol; 2020; 11():622509. PubMed ID: 33633741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1
    Shenderov E; Kandasamy M; Gileadi U; Chen J; Shepherd D; Gibbs J; Prota G; Silk JD; Yewdell JW; Cerundolo V
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34088742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.
    Ju F; Luo Y; Lin C; Jia X; Xu Z; Tian R; Lin Y; Zhao M; Chang Y; Huang X; Li S; Ren W; Qin Y; Yu M; Jia J; Han J; Luo W; Zhang J; Fu G; Ye X; Huang C; Xia N
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4 and CD8 are positive regulators of T cell receptor signal transduction in early T cell differentiation.
    Gilliland LK; Teh HS; Uckun FM; Norris NA; Teh SJ; Schieven GL; Ledbetter JA
    J Immunol; 1991 Mar; 146(6):1759-65. PubMed ID: 1706380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.